ArcticZymes Technologies ASA (OSL:AZT)
Norway
· Delayed Price · Currency is NOK 16.60
+0.15 (0.91%)
May 2, 2025, 4:29 PM CET
OSL:AZT Revenue
In the year 2024, ArcticZymes Technologies ASA had annual revenue of 108.11M NOK, down -9.65%. ArcticZymes Technologies ASA had revenue of 26.44M in the quarter ending December 31, 2024, a decrease of -9.13%.
Revenue
108.11M
Revenue Growth
-9.65%
P/S Ratio
7.84
Revenue / Employee
2.04M
Employees
61
Market Cap
847.79M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 108.11M | -11.54M | -9.65% |
| Dec 31, 2023 | 119.65M | -18.02M | -13.09% |
| Dec 31, 2022 | 137.67M | 6.62M | 5.05% |
| Dec 31, 2021 | 131.05M | 33.23M | 33.96% |
| Dec 31, 2020 | 97.82M | 48.65M | 98.92% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Medistim ASA | 556.16M |
| Nordhealth AS | 537.23M |
| Photocure ASA | 525.39M |
| Vistin Pharma ASA | 440.66M |
| Omda AS | 426.27M |
| Nykode Therapeutics AS | 104.04M |
| Hofseth BioCare ASA | 265.54M |
| Gentian Diagnostics ASA | 152.07M |